Medicare Covers Lung Cancer PET Scans
WASHINGTON--Medicare officials have expanded coverage for positron emission tomography (PET) scans to include their use in assessing lung cancer. Effective Jan. 1, the new coverage allows the use of PET in Medicare patients to determine the type of lung cancer (characterization of single lung nodules) or to do initial staging. Previously, Medicare limited PET coverage to perfusion rate studies in the heart.
WASHINGTON--Medicare officials have expanded coverage for positron emission tomography (PET) scans to include their use in assessing lung cancer. Effective Jan. 1, the new coverage allows the use of PET in Medicare patients to determine the type of lung cancer (characterization of single lung nodules) or to do initial staging. Previously, Medicare limited PET coverage to perfusion rate studies in the heart.
Neoadjuvant Capecitabine Plus Temozolomide in Atypical Lung NETs
Read about a woman with well-differentiated atypical carcinoid who experienced a 21% regression in primary tumor size after 12 months on neoadjuvant capecitabine and temozolomide.
